Navigation Links
Ganeden Biotech Announces Grants for Early Investigators to Research Probiotic GanedenBC30
Date:9/30/2009

CLEVELAND, Sept. 30 /PRNewswire/ -- Ganeden Biotech Inc., makers of the patented probiotic strain GanedenBC30® (Bacillus coagulans GBI-30, 6086), today announced two grants for early investigators. Grants focus on researching the effects of GanedenBC30 on human immune cells. Previous studies have demonstrated the ability of GanedenBC30 to modulate numerous human immune cells, both in vitro and in vivo.

To be eligible, investigators must have a full-time faculty appointment at a research institution or medical school. Applicants must have interest in studying the effects of GanedenBC30 on human immune cells, as well as the capacity to conduct such research.

Two grants will be funded at a maximum of $15,000 for each project. Applicants will be expected to submit a budget outlining how the funds will be used. A meeting with Ganeden's Scientific Board will be required prior to the start of the research, as well as following the research to present the results. Travel for these meetings will be subsidized above the grant amount.

Applications will be reviewed by:

  • Ken Alibek, CEO, AFG Bioscience
  • John Endres, chief scientific officer, AIBMR Life Sciences
  • Sean Farmer, chief scientific officer, Ganeden Biotech
  • Glenn Gibson, professor, University of Reading
  • Gary Huffnagle, professor, University of Michigan
  • David Keller, vice president of scientific operations, Ganeden Biotech

Grant applications will be judged on quality of the proposed experimental design, originality of the proposal, evidence of the applicant's ability to conduct the proposed research, and relevance of the proposed research to the health of the general population.

Please contact Dr. David Keller at keller@ganedenbiotech.com for all request
'/>"/>

SOURCE Ganeden Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Melanoma Cancer Clinical Trial
2. Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC
3. Malaria Vaccine Developer, Sanaria Inc., Receives 2009 Vaccine Industry Excellence Award for Best Early-Stage Vaccine Biotech
4. TriLink BioTechnologies, Inc. Announces Supply Agreement With Osmetech Molecular Diagnostics
5. Oncolytics Biotech(R) Inc. Announces Start of Enrolment in U.S. Phase 2 Combination Clinical Trial for Non-Small Cell Lung Cancer Patients with K-RAS or EGFR-Activated Tumours
6. Cancer Therapy & Research Center at The University of Texas Health Science Center and Oncolytics Biotech(R) Inc. Announce Multi-Trial Clinical Research Collaboration
7. Oncolytics Biotech Inc. Announces Start of Patient Enrolment in Translational Clinical Trial Investigating REOLYSIN(R) in Patients with Metastatic Colorectal Cancer
8. Pulmo BioTech Inc. Announces Dual Listing on Frankfurt Borse
9. PDS Biotechnology Corporation Progresses Development of Nanotechnology Cancer Therapies
10. Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation
11. Researchers at Axial Biotech Develop a DNA Test for Scoliosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014  BC Technical, the nation,s ... Polaris Medical Imaging, a leader in sales, service and ... acquisition allows BC Technical to continue to expand their ... MR and CT modalities. "We are ... Mark Alvarez , president and CEO of BC ...
(Date:8/29/2014)... DENVER , Aug. 29, 2014 Does your ... date, nearly 800 doctors have recommended marijuana to the over ... Amendment 20. But the majority of the other roughly 20,300+ ... still know very little about it – even though a ... adults say they have tried it. ...
(Date:8/29/2014)... Diseases largely eradicated in the ... Measles was declared eliminated in 2000, yet the CDC ... 15—the highest incidence in 20 years. In July, ... cough a problem of "epidemic proportions." ... from these preventable diseases—in part because some parents (more ...
Breaking Medicine Technology:BC Technical Acquires Polaris Medical Imaging 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3
... WESTON, Fla. , June 15 DHL Global Mail ... of mail-order pharmacies. DHL SMARTMAIL PHARMA SELECT ™ incorporates best ... the pharmaceutical industry. Thanks to this expertise and Global Mail,s nationwide ... accountability and value. , , ...
... Perrigo Company (Nasdaq: PRGO;TASE) today announced that Perrigo Executive Vice President ... Goldman Sachs Global Healthcare Conference on Tuesday, June 15 , at ... in Los Angeles .  The presentation will be webcast on the ... , , ...
Cached Medicine Technology:DHL Global Mail Launches Specialized Shipping Service for Mail-Order Pharmacies 2
(Date:8/31/2014)... August 31, 2014 This September, ... California State Library, celebrates 30 years of changing ... Since its inception, California’s Library Literacy Services has ... learn to read and write. , To mark ... the state is launching a month-long awareness campaign ...
(Date:8/31/2014)... Sunday 31 August 2014: Renal denervation seems to ... with resistant hypertension when it includes accessory renal arteries, ... Dr Linda Schmiedel from Germany. , Dr Schmiedel said: ... hypertension, which is defined as blood pressure (BP) greater ... from resistant hypertension (rHTN) and are unable to reduce ...
(Date:8/30/2014)... August 2014: A new method to predict the ... was presented at ESC Congress today by Dr Benjamin ... needs 350 AEDs located in public places for optimal ... Dr Dahan said: "Out of hospital cardiac arrest is ... ranging between 50 and 100 per 100 000 in ...
(Date:8/30/2014)... Walking-Canes.Net has released several articles related ... can help in making gait problems easier. The new ... website that contains all of the news articles that were ... articles deal with diseases that make walking a problem and ... help in making life easier for the patient. The articles ...
(Date:8/30/2014)... Cokato, MN (PRWEB) August 31, 2014 ... renewed in home renovation, especially spa style bathrooms and ... (NASS) has observed an increase in interest not ... understanding the history, culture and health benefits of sauna. ... Finnleo , the North American Sauna Society provides ...
Breaking Medicine News(10 mins):Health News:California Library Literacy Services Celebrates 30th Anniversary 2Health News:California Library Literacy Services Celebrates 30th Anniversary 3Health News:Renal denervation more successful when it includes accessory arteries 2Health News:New method predicts optimal number and location of AEDs 2Health News:Information Articles on Gait Problems from Walking-Canes.Net 2Health News:As Interest in Saunas Increases, the North American Sauna Society Increases Outreach to Provide Education on History, Design, and Culture 2
... compared to kids without disorder , MONDAY, Oct. 19 ... in blood mercury levels between children who are developing ... disorders. , The findings, appearing online Oct. 19 in ... some of the debate surrounding mercury and autism. , ...
... not trained in skin cancer examinations, nor have they ever ... the October issue of Archives of Dermatology , one ... that can be detected early for which U.S. death rates ... Although melanoma remains the second most common cause of cancer ...
... WASHINGTON, D.C., October 19, 2009 With chronic diseases ... solutions to improve care and outcomes for these often ... today announced a new initiative funded with a grant ... will allow pediatricians across the country to pilot a ...
... a joint letter to the Centers for Medicare and ... fluorodeoxyglucose (FDG) positron emission tomography (PET) scans for a ... only one FDG-PET study during initial treatmenta limitation that ... under certain circumstances. "It is absolutely critical for ...
... ... Assara Laser Cosmetic Services Centers and Park Avenue Laser Vision ... dedication to providing exemplary care in the cutting-edge laser cosmetics field. ... laser spider vein removal and laser facials. Park Avenue Laser Vision ...
... ... Access, Choice, and Flexibility. , ... Albany, NY (Vocus) October 19, 2009 -- In a continuous effort to develop products and ... benefits, CDPHP ® announces several enhancements to take effect in 2010 pending New York ...
Cached Medicine News:Health News:Mercury Levels Not Abnormal in Autistic Children 2Health News:Mercury Levels Not Abnormal in Autistic Children 3Health News:Resident physicians seldom trained in skin cancer examination 2Health News:Pediatricians put proven treatment strategies to work against childhood asthma 2Health News:1 scan per patient is not always enough 2Health News:Assara Laser Announces Strategic Alliance with Park Avenue Laser Vision 2Health News:Assara Laser Announces Strategic Alliance with Park Avenue Laser Vision 3Health News:CDPHP Launches National Network and Three-In-One Plan, and Expands Member Incentives 2Health News:CDPHP Launches National Network and Three-In-One Plan, and Expands Member Incentives 3Health News:CDPHP Launches National Network and Three-In-One Plan, and Expands Member Incentives 4
Comfor™ Cast Boot - Rocker Sole - Closed Toe...
The Multi-Purpose Medical-Surgical Shoe...
... assay for the qualitative and ... to Gliadin in human serum. ... be used as an aid ... disorders, mainly Coeliac Disease. This ...
... For use as a non-reactive quality assurance reagent ... Toxoplasma gondii (TOXO IgG and TOXO IgM), IgG ... and rubella IgM), IgG and IgM antibodies to ... IgM antibodies to herpes simplex virus types 1 ...
Medicine Products: